THE Govt will list Voxzogo (vosoritide) on the PBS for treatment of patients with achondroplasia, whose growth plates are not yet closed.
Achondroplasia is a type of skeletal dysplasia or dwarfism, affecting around one in 20,000 babies born in Australia.
Federal Health Minister Mark Butler said, "I want to particularly congratulate the work of the Murdoch Children's Research Institute & Ravi Savarirayan who led BioMarin's development program for Voxzogo, with the world's largest clinical trial site for it".
The above article was sent to subscribers in Pharmacy Daily's issue from 25 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 May 23
